Found: 15
Select item for more details and to access through your institution.
Systematic review of the barriers and facilitators to dietary modification in people living with type 2 diabetes and pre‐diabetes from South Asian ethnic populations.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 8, p. 1, doi. 10.1111/dme.15132
- By:
- Publication type:
- Article
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 4, p. 1, doi. 10.1111/dme.14769
- By:
- Publication type:
- Article
A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post‐COVID‐19 era.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 3, p. 1, doi. 10.1111/dme.14462
- By:
- Publication type:
- Article
Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium–glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020).
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 2, p. 1, doi. 10.1111/dme.14458
- By:
- Publication type:
- Article
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice.
- Published in:
- Drugs, 2022, v. 82, n. 2, p. 97, doi. 10.1007/s40265-021-01655-2
- By:
- Publication type:
- Article
Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors.
- Published in:
- Drugs, 2021, v. 81, n. 11, p. 1243, doi. 10.1007/s40265-021-01538-6
- By:
- Publication type:
- Article
Type 2 Diabetes Is Associated with Reduced ATP-Binding Cassette Transporter A1 Gene Expression, Protein and Function.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022142
- By:
- Publication type:
- Article
ABCD position statement on risk stratification of adult patients with diabetes during COVID-19 pandemic.
- Published in:
- British Journal of Diabetes, 2021, v. 21, n. 1, p. 123, doi. 10.15277/bjd.2021.282
- By:
- Publication type:
- Article
Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose co-transporter inhibitors with insulin for treatment of type 1 diabetes (updated October 2020).
- Published in:
- British Journal of Diabetes, 2020, v. 20, n. 2, p. 155, doi. 10.15277/bjd.2020.265
- By:
- Publication type:
- Article
Real‐world data of a digitally enabled, time‐restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A service evaluation of the Roczen program.
- Published in:
- Obesity Science & Practice, 2024, v. 10, n. 1, p. 1, doi. 10.1002/osp4.730
- By:
- Publication type:
- Article
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 889, doi. 10.1007/s13300-022-01242-y
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 9, p. 2267, doi. 10.1007/s13300-021-01116-9
- By:
- Publication type:
- Article
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 5, p. 1595, doi. 10.1007/s13300-019-0657-8
- By:
- Publication type:
- Article
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 33, doi. 10.1007/s12325-021-01927-z
- By:
- Publication type:
- Article